1101/1507US=90 / Biol/Mol
Eberhard DA. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR mutations, other molecular alterations related to sensitivity to EGFR-targeted therapies in non-small cell lung cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 293-336. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DE QUINASE DE TIROSINA; DIAGNOSTICOS MOLECULARES; MUTACOES; HIBRIDACAO IN SITU FLUORESCENTE; IMUNOHISTOQUIMICA; CANCER DE PULMAO

1102/1507US=90 / Biol/Mol
Dannenberg AJ, Subbaramaiah K. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: crosstalk between COX-2 and EGFR: apontential therapeutic opportunity. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 337-51. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CICLOOXIGENASE-2; PROSTAGLANDINAS; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; CROSSTALK; CANCER

1103/1507US=90 / Biol/Mol
Thomson S, Haley JD, Yauch R. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: cellular sensitivity to EGF receptor inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 353-68. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; HER2; HER3; ERLOTINIB; A TRANSICAO EPITELIAL MESENQUIMAL; INIBIDORES DE QUINASE DE TIROSINA

1104/1507US=90 / Biol/Mol
Buck E, Eyzaguirre A, Iwata KK. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: utilizing combination of molecular targeted agents to sensitize tumor cells to EGFR inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 369-82. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EMT; TRANSICAO EPITELIAL MESENQUIMAL; ERLOTINIB; EGFR; IGF-1R; ER; HER3; MTOR; HDAC; SRC; COX-2

1105/1507US=98 / Biol/Mol
Kerr JFR. A personal history of the development of the apoptosis concept. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 1-11. ISBN 978-084939192-7.

HISTORIA CONCEITO DE APOPTOSE; DESENVOLVIMENTO DO CONCEITO DE APOPTOSE; ENCOLHIMENTO; NECROSE; TUMORES MALIGNOS

1106/1507US=98 / Biol/Mol
Wilson GD. What do the clinical data tell us about the role of apoptosis in sensitivity to cancer therapy?. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 13-39. ISBN 978-084939192-7.

PAPEL DA APOPTOSE; TERAPIA DO CANCER. SENSIBILIDADE

1107/1507US=98 / Biol/Mol
Brown M. Response of solid tumors to cancer therapy: how relevant is apoptosis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 41-53. ISBN 978-084939192-7.

RESPOSTA DE TUMORES SOLIDOS; TRATAMENTO DE CANCER; APOPTOSE

1108/1507US=98 / Biol/Mol
Lockshin RA, Zakeri Z. Historical studies of various forms of cells death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 55-72. ISBN 978-084939192-7.

MORTE DE CELULAS. TIPOS; MORTE CELULAR LISOSSOMAL

1109/1507US=98 / Biol/Mol
Bredesen DE. Toward a mechanistic taxonomy for programmed cell death pathways. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 73-91. ISBN 978-084939192-7.

MORTE CELULAR PROGRAMADA; TAXONOMIA MECANICISTA; APOPTOSE

1110/1507US=98 / Biol/Mol
Egger L. Caspase-independent apoptotic cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 93-108. ISBN 978-084939192-7.

CASPASE-INDEPENDENTE DE MORTE CELULAR POR APOPTOSE; INIBICAO DA CASPASE; SINTETICOS INIBIDORES DE CASPASES; CASPASE-MORTE CELULAR INDEPENDENTE

1111/1507US=98 / Biol/Mol
Madden DT. Autophagic cell death in mammalian cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 109-26. ISBN 978-084939192-7.

MORTE CELULAR; CELULAS DE MAMIFEROS AUTOFAGICA; AUTOFAGIA E CANCER

1112/1507US=98 / Biol/Mol
Fan Y, Ullman E, Zong WX. The cellular decision between apoptosis and autophagy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 127-41. ISBN 978-084939192-7.

DECISAO CELULAR; APOPTOSE; AUTOFAGIA; DNA-PK

1113/1507US=98 / Biol/Mol
Dawson VL, Dawson TM. Parthanatos: PARP - and AIF-dependent programmed cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 143-56. ISBN 978-084939192-7.

PARTHANATOS; PARP; FIA; MORTE CELULAR PROGRAMADA; POLYMERASE-1

1114/1507US=98 / Biol/Mol
Sperandio S, Belle I. Paraptosis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 157-74. ISBN 978-084939192-7.

PARAPTOSIS

1115/1507US=98 / Biol/Mol
Campisi J. Cellular senescence and its effects on carcinogenesis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 175-93. ISBN 978-084939192-7.

SENESCENCIA CELULAR; CARCINOGENESE. EFEITOS; SENESCENCIA CELULAR E OS SEUS EFEITOS SOBRE A CARCINOGENESE; SENESCENCIA CELULAR SUPRIME CANCER; CANCER E ENVELHECIMENTO; SENESCENCIA CELULAR E CANCER

1116/1507US=98 / Biol/Mol
Nickoloff BJ. Tumor suppressing activities of senescent keratinocytes. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 195-207. ISBN 978-084939192-7.

TUMORAIS SUPRIMINDO; ATIVIDADES DE QUERATINOCITOS SENESCENTES

1117/1507US=98 / Biol/Mol
DiMaio D, Johung K, Goodwin EC, Horner SM, Yates KE. Senescence induced by repression of human papillomavirus oncogenes in cervical cancer cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 209-222. ISBN 978-084939192-7.

SENESCENCIA INDUZIDA; REPRESSAO DOS ONCOGENES; CELULAS DE CANCER DO COLO DO UTERO. PAPILOMAVIRUS HUMANO

1118/1507US=98 / Biol/Mol
Roninson IB, Broude EV. Treatment-induced tumor cell senescence and its consequences. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 223-49. ISBN 978-084939192-7.

CELULAS TUMORAIS. TRATAMENTO SENESCENCIA; ANTICARCINOGENICO; SENESCENCIA CELULAR TUMORAL

1119/1507US=98 / Biol/Mol
Rebbaa A. Senescence regulation in cancer therapy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 251-71. ISBN 978-084939192-7.

REGULACAO SENESCENCIA. TERAPIA DO CANCER

1120/1507US=98 / Biol/Mol
Kilic M, Schmitt CA. Exploiting drug-induced senescence in transgenic mouse models. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 273-94. ISBN 978-084939192-7.
Primeira | Anterior | Próxima | Última